Works matching IS 17597706 AND DT 2024 AND VI 15 AND IP 5

Results: 13

With regard to the original article "A case of primary lung adenocarcinoma mimicking metastatic papillary thyroid carcinoma".

Published in:

Thoracic Cancer, 2024, v. 15, n. 5, p. 434, doi. 10.1111/1759-7714.15223

By:

Hanamatsu, Yuki;
Yada, Yuki;
Shirahashi, Koyo;
Takeuchi, Tamotsu

Publication type:

Article

Efficacy of osimertinib in patients with EGFR‐mutation positive non‐small cell lung cancer with malignant pleural effusion.

Published in:

Thoracic Cancer, 2024, v. 15, n. 5, p. 402, doi. 10.1111/1759-7714.15210

By:

Kiritani, Ayu;
Amino, Yoshiaki;
Uchibori, Ken;
Akita, Takahiro;
Harutani, Yuhei;
Ogusu, Shinsuke;
Tsugitomi, Ryosuke;
Manabe, Ryo;
Ariyasu, Ryo;
Kitazono, Satoru;
Yanagitani, Noriko;
Nishio, Makoto

Publication type:

Article

Rechallenge of immune checkpoint inhibitors in advanced non‐small cell lung cancer.

Published in:

Thoracic Cancer, 2024, v. 15, n. 5, p. 419, doi. 10.1111/1759-7714.15209

By:

Lin, Gen;
Wang, Zhijie;
Chu, Qian;
Hu, Yi;
Huang, Dingzhi;
Wang, Jun;
Yang, Fan;
Zhong, Wenzhao;
Zhou, Chengzhi;
Zhu, Bo;
Ai, Xinghao;
Cao, Baoshan;
Cao, Yabing;
Chen, Mingqiu;
Chen, Xiaohui;
Chu, Tianqing;
Duan, Jianchun;
Fan, Yun;
Fang, Yong;
Feng, Shuitu

Publication type:

Article

A study protocol for an open‐label, single‐arm, single‐center phase I clinical study on tolerability, safety, and efficacy of dalpiciclib combined with apatinib in the treatment of patients with advanced or metastatic sarcoma.

Published in:

Thoracic Cancer, 2024, v. 15, n. 5, p. 427, doi. 10.1111/1759-7714.15208

By:

Huang, Huiying;
Zhang, Hua;
Cao, Baoshan

Publication type:

Article

Real‐world survival outcomes of immunotherapy for advanced non‐small cell lung cancer: A single‐center retrospective review.

Published in:

Thoracic Cancer, 2024, v. 15, n. 5, p. 394, doi. 10.1111/1759-7714.15205

By:

Punchhi, Gopika;
Hussein, Abdulkadir;
Kulkarni, Swati

Publication type:

Article

A case of inflammatory myofibroblastic tumor harboring EML4‐ALK fusion with a brain metastasis responding to alectinib.

Published in:

Thoracic Cancer, 2024, v. 15, n. 5, p. 415, doi. 10.1111/1759-7714.15203

By:

Sakoda, Soichiro;
Tanaka, Kentaro;
Koga, Yuichiro;
Mikumo, Hironori;
Tsuchiya‐Kawano, Yuko;
Harada, Eiji;
Tamiya, Sadafumi;
Okamoto, Isamu

Publication type:

Article

Comparison of primary and metastatic site‐related PD‐L1 expression in predicting ORR in patients with advanced NSCLC who received ICB‐based therapy.

Published in:

Thoracic Cancer, 2024, v. 15, n. 5, p. 379, doi. 10.1111/1759-7714.15201

By:

Zhou, Danhong;
Wang, Yang;
Ning, Weiwei;
Chen, Cheng

Publication type:

Article

Potential of fluoropyrimidine to be an immunologically optimal partner of immune checkpoint inhibitors through inducing immunogenic cell death for thoracic malignancies.

Published in:

Thoracic Cancer, 2024, v. 15, n. 5, p. 369, doi. 10.1111/1759-7714.15200

By:

Kozai, Hiroyuki;
Ogino, Hirokazu;
Mitsuhashi, Atsushi;
Nguyen, Na Thi;
Tsukazaki, Yuki;
Yabuki, Yohei;
Ozaki, Ryohiko;
Yoneda, Hiroto;
Sato, Seidai;
Hanibuchi, Masaki;
Shinohara, Tsutomu;
Nokihara, Hiroshi;
Nishioka, Yasuhiko

Publication type:

Article

Value of CT‐based radiomics in evaluating the response of bone metastases to systemic drug therapy in breast cancer patients.

Published in:

Thoracic Cancer, 2024, v. 15, n. 5, p. 361, doi. 10.1111/1759-7714.15199

By:

He, Miao;
Wang, Dongdong;
Li, Huijie;
Sun, Meili;
Yan, Peng;
Zhang, Yongyuan;
Li, Li;
Yu, Dexin;
Wang, Xiuwen;
Hu, Yu

Publication type:

Article

Primary pulmonary adenoid cystic carcinoma: A clinicopathological study of 64 patients.

Published in:

Thoracic Cancer, 2024, v. 15, n. 5, p. 386, doi. 10.1111/1759-7714.15202

By:

Tan, Xiang;
Xu, Tao;
Shen, Wang;
Ai, Cheng;
Zhang, Weilin;
Tang, Xiaojun;
Luo, Feng;
Zhou, Qinghua

Publication type:

Article

Difficulty differentiating primary mediastinal classical Hodgkin lymphoma from inflammatory myofibroblastic tumor: A case report.

Published in:

Thoracic Cancer, 2024, v. 15, n. 5, p. 410, doi. 10.1111/1759-7714.15197

By:

Akata, Kentaro;
Yamasaki, Kei;
Chiba, Yosuke;
Kawaguchi, Takako;
Dosaka, Hiroki;
Morimoto, Toshiki;
Higashi, Yasuyuki;
Nishida, Chinatsu;
Shimajiri, Shohei;
Yatera, Kazuhiro

Publication type:

Article

Correction to "Epiplakin1 promotes the progression of esophageal squamous cell carcinoma by activating the PI3K‐AKT signaling pathway".

Published in:: Thoracic Cancer, 2024, v. 15, n. 5, p. 436, doi. 10.1111/1759-7714.15195
Publication type:: Article

Issue Information.

Published in:: Thoracic Cancer, 2024, v. 15, n. 5, p. 359, doi. 10.1111/1759-7714.14948
Publication type:: Article